Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Hydrogen sulfide is an endogenous potentiator of T cell activation.

Miller TW, Wang EA, Gould S, Stein EV, Kaur S, Lim L, Amarnath S, Fowler DH, Roberts DD.

J Biol Chem. 2012 Feb 3;287(6):4211-21. doi: 10.1074/jbc.M111.307819. Epub 2011 Dec 13.

2.

Thrombospondin-1 is a CD47-dependent endogenous inhibitor of hydrogen sulfide signaling in T cell activation.

Miller TW, Kaur S, Ivins-O'Keefe K, Roberts DD.

Matrix Biol. 2013 Aug 8;32(6):316-24. doi: 10.1016/j.matbio.2013.02.009. Epub 2013 Mar 13.

3.

CD47-dependent regulation of H₂S biosynthesis and signaling in T cells.

Kaur S, Schwartz AL, Miller TW, Roberts DD.

Methods Enzymol. 2015;555:145-68. doi: 10.1016/bs.mie.2014.11.023. Epub 2015 Jan 8.

PMID:
25747479
4.

Curcumin inhibits CD4(+) T cell activation, but augments CD69 expression and TGF-β1-mediated generation of regulatory T cells at late phase.

Kim G, Jang MS, Son YM, Seo MJ, Ji SY, Han SH, Jung ID, Park YM, Jung HJ, Yun CH.

PLoS One. 2013 Apr 26;8(4):e62300. doi: 10.1371/journal.pone.0062300. Print 2013. Erratum in: PLoS One. 2013;8(5). doi: 10.1371/annotation/631b0f02-bf10-4bac-88a3-c986f2b73284.

5.

IRF2BP2 transcriptional repressor restrains naive CD4 T cell activation and clonal expansion induced by TCR triggering.

Sécca C, Faget DV, Hanschke SC, Carneiro MS, Bonamino MH, de-Araujo-Souza PS, Viola JP.

J Leukoc Biol. 2016 Nov;100(5):1081-1091. Epub 2016 Jun 10.

6.

Mycobacterial antigen(s) induce anergy by altering TCR- and TCR/CD28-induced signalling events: insights into T-cell unresponsiveness in leprosy.

Dagur PK, Sharma B, Kumar G, Khan NA, Katoch VM, Sengupta U, Joshi B.

Mol Immunol. 2010 Feb;47(5):943-52. doi: 10.1016/j.molimm.2009.11.009. Epub 2009 Dec 16.

PMID:
20018378
7.

Aurora A drives early signalling and vesicle dynamics during T-cell activation.

Blas-Rus N, Bustos-Morán E, Pérez de Castro I, de Cárcer G, Borroto A, Camafeita E, Jorge I, Vázquez J, Alarcón B, Malumbres M, Martín-Cófreces NB, Sánchez-Madrid F.

Nat Commun. 2016 Apr 19;7:11389. doi: 10.1038/ncomms11389.

8.

Acquisition of anergic and suppressive activities in transforming growth factor-beta-costimulated CD4+CD25- T cells.

Park HB, Paik DJ, Jang E, Hong S, Youn J.

Int Immunol. 2004 Aug;16(8):1203-13. Epub 2004 Jul 5.

PMID:
15237111
10.

The Nrf2 activator, tBHQ, differentially affects early events following stimulation of Jurkat cells.

Zagorski JW, Turley AE, Dover HE, VanDenBerg KR, Compton JR, Rockwell CE.

Toxicol Sci. 2013 Nov;136(1):63-71. doi: 10.1093/toxsci/kft172. Epub 2013 Aug 14.

11.

The effect of rhG-CSF on the conformation of LFA-1 on CD4+ T cells in hemopoietic stem cell transplantation.

Weihua C, Fei W, Meng L, Haiyan Z, Wanming D, Chunji G.

Immunopharmacol Immunotoxicol. 2009 Jun;31(2):267-73. doi: 10.1080/08923970802530510.

PMID:
19235605
12.

Raman spectroscopic modeling of early versus late T-lymphocyte activation via differential spectral detection of receptor expression.

Brown KL, Palyvoda OY, Auner GW, Gruber SA.

J Immunol Methods. 2014 Dec 15;415:31-5. doi: 10.1016/j.jim.2014.10.001. Epub 2014 Oct 20.

PMID:
25450257
13.

Ex vivo enzymatic treatment of aged CD4 T cells restores antigen-driven CD69 expression and proliferation in mice.

Garcia GG, Miller RA.

Immunobiology. 2011 Jan-Feb;216(1-2):66-71. doi: 10.1016/j.imbio.2010.03.003. Epub 2010 Mar 16.

14.

CD69 does not affect the extent of T cell priming.

Alari-Pahissa E, Notario L, Lorente E, Vega-Ramos J, Justel A, López D, Villadangos JA, Lauzurica P.

PLoS One. 2012;7(10):e48593. doi: 10.1371/journal.pone.0048593. Epub 2012 Oct 30.

15.

The early activation marker CD69 regulates the expression of chemokines and CD4 T cell accumulation in intestine.

Radulovic K, Rossini V, Manta C, Holzmann K, Kestler HA, Niess JH.

PLoS One. 2013 Jun 12;8(6):e65413. doi: 10.1371/journal.pone.0065413. Print 2013.

16.

Imatinib inhibits T-cell receptor-mediated T-cell proliferation and activation in a dose-dependent manner.

Seggewiss R, Loré K, Greiner E, Magnusson MK, Price DA, Douek DC, Dunbar CE, Wiestner A.

Blood. 2005 Mar 15;105(6):2473-9. Epub 2004 Nov 30.

17.

Alloreactive CD8 T cells rescued from apoptosis during co-stimulation blockade by Toll-like receptor stimulation remain susceptible to Fas-induced cell death.

Priyadharshini B, Thornley TB, Daniels KA, Cuthbert A, Welsh RM, Greiner DL, Brehm MA.

Immunology. 2013 Apr;138(4):322-32. doi: 10.1111/imm.12044.

18.

Interaction of hydrogen sulfide and estrogen on the proliferation of vascular smooth muscle cells.

Li H, Mani S, Cao W, Yang G, Lai C, Wu L, Wang R.

PLoS One. 2012;7(8):e41614. doi: 10.1371/journal.pone.0041614. Epub 2012 Aug 3.

19.

In CD28-costimulated human naïve CD4+ T cells, I-κB kinase controls the expression of cell cycle regulatory proteins via interleukin-2-independent mechanisms.

Lupino E, Buccinnà B, Ramondetti C, Lomartire A, De Marco G, Ricotti E, Tovo PA, Rinaudo MT, Piccinini M.

Immunology. 2010 Oct;131(2):231-41. doi: 10.1111/j.1365-2567.2010.03297.x.

20.

CD69 regulates type I IFN-induced tolerogenic signals to mucosal CD4 T cells that attenuate their colitogenic potential.

Radulovic K, Manta C, Rossini V, Holzmann K, Kestler HA, Wegenka UM, Nakayama T, Niess JH.

J Immunol. 2012 Feb 15;188(4):2001-13. doi: 10.4049/jimmunol.1100765. Epub 2012 Jan 16.

Supplemental Content

Support Center